GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (STU:CP60) » Definitions » Interest Expense

The Cooper (STU:CP60) Interest Expense : €-104 Mil (TTM As of Apr. 2024)


View and export this data going back to 1983. Start your Free Trial

What is The Cooper Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. The Cooper's interest expense for the three months ended in Apr. 2024 was € -27 Mil. Its interest expense for the trailing twelve months (TTM) ended in Apr. 2024 was €-104 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. The Cooper's Operating Income for the three months ended in Apr. 2024 was € 151 Mil. The Cooper's Interest Expense for the three months ended in Apr. 2024 was € -27 Mil. The Cooper's Interest Coverage for the quarter that ended in Apr. 2024 was 5.60. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


The Cooper Interest Expense Historical Data

The historical data trend for The Cooper's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Interest Expense Chart

The Cooper Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -61.47 -31.28 -19.91 -58.16 -99.72

The Cooper Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.80 -24.23 -24.91 -27.45 -26.94

The Cooper Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-104 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Cooper  (STU:CP60) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

The Cooper's Interest Expense for the three months ended in Apr. 2024 was €-27 Mil. Its Operating Income for the three months ended in Apr. 2024 was €151 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Apr. 2024 was €2,490 Mil.

The Cooper's Interest Coverage for the quarter that ended in Apr. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Apr. 2024 )/Interest Expense (Q: Apr. 2024 )
=-1*150.704/-26.935
=5.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


The Cooper (STU:CP60) Business Description

Traded in Other Exchanges
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (STU:CP60) Headlines

No Headlines